koncentrat till infusionsvätska

DRUG3 trials

Sponsors

Karolinska University Hospital, Oulu University Hospital, Aalborg University Hospital

Conditions

HSV-2 meningitisLymphomaPrimaari aivolymfomaaensilinjan hoito tai hoito relapoituneessa tai refraktaarissa taudissa

Phase 2

Hyper-CVAD/MA for high-risk aggressive B-cell lymphomas: a single-centre academic phase II trial (HYPERION)

RecruitingCTIS2023-505990-34-00

Karolinska University HospitalLymphoma

Start: 2024-11-08Target: 183Updated: 2024-07-08

Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous system lymphoma

Not yet recruitingCTIS2024-519046-79-00

Oulu University Hospitalensilinjan hoito tai hoito relapoituneessa tai refraktaarissa taudissa, Primaari aivolymfomaa

Target: 100Updated: 2024-12-20

Phase 4

Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN)

Not yet recruitingCTIS2024-520042-31-00

Aalborg University HospitalHSV-2 meningitis

Target: 150Updated: 2025-01-02